These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 9039119

  • 1. Vascular smooth muscle thromboxane A2 receptors mediate arachidonic acid-induced sudden death in rabbits.
    Pfister SL, Kotulock DA, Campbell WB.
    Hypertension; 1997 Jan; 29(1 Pt 2):303-9. PubMed ID: 9039119
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the thromboxane (TP-) receptor subtype involved in proliferation in cultured vascular smooth muscle cells of rat.
    Ko FN, Yu SM, Kang YF, Teng CM.
    Br J Pharmacol; 1995 Sep; 116(2):1801-8. PubMed ID: 8528563
    [Abstract] [Full Text] [Related]

  • 3. Thromboxane A2 and vascular smooth muscle cell proliferation.
    Sachinidis A, Flesch M, Ko Y, Schrör K, Böhm M, Düsing R, Vetter H.
    Hypertension; 1995 Nov; 26(5):771-80. PubMed ID: 7591017
    [Abstract] [Full Text] [Related]

  • 4. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S, Nakahata N, Ohizumi Y.
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [Abstract] [Full Text] [Related]

  • 5. Thromboxane/prostaglandin endoperoxide-induced hypertrophy of rat vascular smooth muscle cells is signaled by protein kinase C-dependent increases in transforming growth factor-beta.
    Craven PA, Studer RK, DeRubertis FR.
    Hypertension; 1996 Aug; 28(2):169-76. PubMed ID: 8707377
    [Abstract] [Full Text] [Related]

  • 6. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C, Rousselot C, Chavernac G, Depin JC, Guerrier D.
    Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
    [Abstract] [Full Text] [Related]

  • 7. Amplifying interactions between spasmogens in vascular smooth muscle.
    MacLennan SJ, Bolofo ML, Martin GR.
    Biochem Soc Trans; 1993 Nov; 21(4):1145-50. PubMed ID: 8131914
    [No Abstract] [Full Text] [Related]

  • 8. Molecular and functional evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2.
    Yura T, Fukunaga M, Grygorczyk R, Makita N, Takahashi K, Badr KF.
    Adv Prostaglandin Thromboxane Leukot Res; 1995 Nov; 23():237-9. PubMed ID: 7732843
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 10. Thromboxane receptors in smooth muscle promote hypertension, vascular remodeling, and sudden death.
    Sparks MA, Makhanova NA, Griffiths RC, Snouwaert JN, Koller BH, Coffman TM.
    Hypertension; 2013 Jan; 61(1):166-73. PubMed ID: 23150508
    [Abstract] [Full Text] [Related]

  • 11. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
    Dorn GW, Becker MW, Davis MG.
    J Biol Chem; 1992 Dec 05; 267(34):24897-905. PubMed ID: 1447225
    [Abstract] [Full Text] [Related]

  • 12. Decrease in vascular TxA2 receptors in a subgroup of rabbits unresponsive to a TxA2 mimetic.
    Buzzard CJ, Pfister SL, Halushka PV, Campbell WB.
    Am J Physiol; 1994 Jun 05; 266(6 Pt 2):H2320-6. PubMed ID: 8023992
    [Abstract] [Full Text] [Related]

  • 13. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH, Woodward DF, Gibson LL, Protzman CE, Williams LS, Burk RM, Gac TS, Roof MB, Abbas F, Marshall K, Senior J.
    Br J Pharmacol; 1996 Mar 05; 117(6):1171-80. PubMed ID: 8882612
    [Abstract] [Full Text] [Related]

  • 14. Reduced thromboxane receptor affinity and vasoconstrictor responses in placentae from diabetic pregnancies.
    Wilkes BM, Mento PF, Hollander AM.
    Placenta; 1994 Dec 05; 15(8):845-55. PubMed ID: 7886025
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L, Fitzgerald DJ, Fitzgerald GA.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):74-81. PubMed ID: 1830100
    [Abstract] [Full Text] [Related]

  • 16. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.
    Jones DA, Benjamin CW, Linseman DA.
    Mol Pharmacol; 1995 Nov 01; 48(5):890-6. PubMed ID: 7476920
    [Abstract] [Full Text] [Related]

  • 17. Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs.
    Schrör K, Morinelli TA, Masuda A, Matsuda K, Mathur RS, Halushka PV.
    Eur J Clin Invest; 1994 Feb 01; 24 Suppl 1():50-2. PubMed ID: 8013532
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of thromboxane A2 on thoracic aorta of young and old rats: use of selective thromboxane receptor antagonists.
    Shams G, Wallace LJ, Miller DD, Feller DR.
    Pharmacology; 1990 Feb 01; 40(1):27-32. PubMed ID: 2139513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.